Stocks
Dicerna Pharmaceuticals (DRNA) EBITDA US GAAP (year values) |
|||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -58.7 | -59.3 | -87.5 | -119.2 | -110.5 | -118.5 | ||
| Changes by years, y/y, % | -6% | +1% | +48% | +36% | -7% | +12.2% | |||
Dicerna Pharmaceuticals. EBITDA US GAAP, bln rub
Dicerna Pharmaceuticals. EBITDA US GAAP, changes, %
Dicerna Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Dicerna Pharmaceuticals (DRNA) EBITDA US GAAP (quarter values) |
||||||||
| FY2020Q3 | FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -21.3 | -36.0 | -29.1 | -38.6 | -14.8 | -118.5 | |
| Changes by years, y/y, % | -30% | -8% | +33% | +23% | -30% | |||
| Changes by quarters, q/q, % | -32% | +69% | -19% | +32% | -62% | |||
